Carmat rises after FY sales

Carmat SA

09/01/2025 09:07

** Shares in Carmat  ALCAR.PA  rise around 3% after the
French artificial heart maker published full-year update
    ** FY sales rose 150% to 7 million euros ($7.21 million),
cash burn was down 20% compared to 2023
    ** Degroof Petercam notes sales came in below 8-12 million
euro guidance, but is "not too worried about this slower start
as early stages of launch are often challenging for a medtech"
    ** It, however, believes that commercial success of its
artificial heart Aeson will be crucial in attracting capital
    ** Carmat expects sales to at least double in 2025, in line
with Degroof's estimates
    ** Including today's rise, stock is up 1.47% YTD after a 84%
drop in 2024

($1 = 0.9705 euros)

 (Reporting by Olivier Cherfan)
 ((olivier.cherfan@thomsonreuters.com))